A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12792. Epub 2017 Nov 27.

Abstract

Scedosporium species are fungal pathogens increasingly recognized in cystic fibrosis (CF). They can cause multiresistant, life-threatening infections that are of particular concern in CF patients undergoing lung transplantation, as optimal treatment remains unclear. Here, we describe our Zurich experience of CF patients with Scedosporium infection. Disseminated infection occurred in one patient after transplantation and was successfully treated. We propose a step-by-step approach to treat candidates with colonization, and discuss our cases in the context of the current literature.

Keywords: Scedosporium; cystic fibrosis; lung transplantation; scedosporiosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Cystic Fibrosis / microbiology
  • Female
  • Humans
  • Lung Transplantation / adverse effects*
  • Male
  • Mycetoma / drug therapy
  • Mycoses / epidemiology*
  • Mycoses / microbiology
  • Scedosporium / isolation & purification*
  • Switzerland / epidemiology
  • Transplant Recipients*
  • Voriconazole / therapeutic use
  • Young Adult

Substances

  • Antifungal Agents
  • Voriconazole